These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 22611756)
21. Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells. Enomoto K; Mimura T; Harris DL; Joyce NC Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4330-40. PubMed ID: 17003423 [TBL] [Abstract][Full Text] [Related]
22. Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study. Han CP; Kok LF; Lee MY; Wu TS; Ruan A; Cheng YW; Wang PH; Koo CL; Tyan YS Arch Gynecol Obstet; 2010 Feb; 281(2):317-23. PubMed ID: 19444461 [TBL] [Abstract][Full Text] [Related]
23. Histologic and immunohistochemical analyses of endometrial carcinomas: experiences from endometrial biopsies in 358 consultation cases. Wei JJ; Paintal A; Keh P Arch Pathol Lab Med; 2013 Nov; 137(11):1574-83. PubMed ID: 24168495 [TBL] [Abstract][Full Text] [Related]
24. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium. Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946 [TBL] [Abstract][Full Text] [Related]
25. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
27. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. McCluggage WG; Jenkins D Int J Gynecol Pathol; 2003 Jul; 22(3):231-5. PubMed ID: 12819388 [TBL] [Abstract][Full Text] [Related]
28. p16 is consistently expressed in endometrial tubal metaplasia. Horree N; Heintz AP; Sie-Go DM; van Diest PJ Cell Oncol; 2007; 29(1):37-45. PubMed ID: 17429140 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor. Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020 [TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604 [TBL] [Abstract][Full Text] [Related]
31. Mammaglobin expression in gynecologic adenocarcinomas. Hagemann IS; Pfeifer JD; Cao D Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633 [TBL] [Abstract][Full Text] [Related]
33. Endometrial Carcinomas With Clear Cells: A Study of a Heterogeneous Group of Tumors Including Interobserver Variability, Mutation Analysis, and Immunohistochemistry With HNF-1β. Han G; Soslow RA; Wethington S; Levine DA; Bogomolniy F; Clement PB; Köbel M; Gilks B; DeLair D Int J Gynecol Pathol; 2015 Jul; 34(4):323-33. PubMed ID: 25851704 [TBL] [Abstract][Full Text] [Related]
34. Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study. Kok LF; Lee MY; Tyan YS; Wu TS; Cheng YW; Kung MF; Wang PH; Han CP Arch Gynecol Obstet; 2010 Feb; 281(2):293-300. PubMed ID: 19418062 [TBL] [Abstract][Full Text] [Related]
35. Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors. Buchynska LG; Nesina IP; Yurchenko NP; Bilyk OO; Grinkevych VN; Svintitsky VS Exp Oncol; 2007 Mar; 29(1):49-53. PubMed ID: 17431389 [TBL] [Abstract][Full Text] [Related]
36. Dysregulation of CDK inhibitors and p53 in HPV-negative endocervical adenocarcinoma. Omori M; Hashi A; Kondo T; Katoh R; Hirata S Int J Gynecol Pathol; 2015 Mar; 34(2):196-203. PubMed ID: 25675191 [TBL] [Abstract][Full Text] [Related]
37. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma. Cheng JD; Werness BA; Babb JS; Meropol NJ Clin Cancer Res; 1999 May; 5(5):1057-62. PubMed ID: 10353738 [TBL] [Abstract][Full Text] [Related]
38. Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough? Liao CL; Hsu JD; Lee MY; Kok LF; Li YJ; Wang PH; Yao CC; Han CP Virchows Arch; 2010 Apr; 456(4):377-86. PubMed ID: 20221633 [TBL] [Abstract][Full Text] [Related]
39. The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators. Horrée N; van Diest PJ; Sie-Go DM; Heintz AP Hum Pathol; 2007 Aug; 38(8):1232-8. PubMed ID: 17490724 [TBL] [Abstract][Full Text] [Related]
40. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis. Lu X; Toki T; Konishi I; Nikaido T; Fujii S Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]